These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons. Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238 [TBL] [Abstract][Full Text] [Related]
10. Biochemical studies in Huntington's chorea. VI. Composition of striatal neutral lipids, phospholipids, glycolipids, fatty acids, and amino acids. Borri PF; Op den Velde WM; Hooghwinkel GJ; Bruyn GW Neurology; 1967 Feb; 17(2):172-8. PubMed ID: 4225234 [No Abstract] [Full Text] [Related]
11. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice. Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326 [TBL] [Abstract][Full Text] [Related]
12. Huntington's disease: studies on brain free amino acids. Bonilla E; Prasad AL; Arrieta A Life Sci; 1988; 42(11):1153-8. PubMed ID: 2894604 [TBL] [Abstract][Full Text] [Related]
13. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease. Dure LS; Young AB; Penney JB Ann Neurol; 1991 Dec; 30(6):785-93. PubMed ID: 1665055 [TBL] [Abstract][Full Text] [Related]